Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list

2008 ◽  
Vol 17 (6) ◽  
pp. 548-555 ◽  
Author(s):  
Eun-Jung Shim ◽  
Yong-Wook Shin ◽  
Hong Jin Jeon ◽  
Bong-Jin Hahm
2014 ◽  
Vol 21 (2) ◽  
pp. 51-56 ◽  
Author(s):  
Ūla Lunevičiūtė ◽  
Egidija Masteikienė

Background. Distress of cancer patients is often left unnoticed and it induces various problems: it is harder for patients to adjust to the illness, the quality of life is poorer, it causes much distress for the team of oncologists. 1 year before in the VU Institute of Oncology the Distress Thermometer was started to be used for all patients in the hospital. Purpose. To explore distress prevalence and features of cancer patients’ in the hospital. Participants and methods. There were 488 participants. The Distress Thermometer (DT) was used to evaluate distress of the participants. DT consists of a Likert type scale from 0 to 10 that assesses the strength of experienced distress, and a problem list that includes practical, family, emotional, spiritual and physical problem groups. Results. The mean score of distress of all participants was 3.47 (SD = 2.47). 82% of participants pointed from 0 to 5 scores, 18% of participants indicated from 6 to 10 scores. There was a statistically significant corellation between the distress score and the number of problems (r = 0.43, p 


2019 ◽  
Vol 21 (Supplement_3) ◽  
pp. iii8-iii9
Author(s):  
M Renovanz ◽  
J Coburger ◽  
G Tabatabai ◽  
F Ringel ◽  
C Wirtz ◽  
...  

Abstract BACKGROUND Patient-centered assessments and disease-adjusted patient-reported outcome measures (PROMs) are crucial in neuro-oncology. The Distress Thermometer (DT) is a well-accepted screening tool for cancer patients including a numerical rating scale (1–10, cut-offs indicating relevant distress ≥4–6) and 40 items describing possible problem categories (emotional, social, physical, practical and spiritual). The aims of the first part of the “Adaption of the Distress Thermometer in patients with intracranial tumors” (HEAT) study were to evaluate the importance and relevance of items for brain tumor patients (BTP). MATERIAL AND METHODS The multicenter study included three University hospitals. After given informed consent patients were prospectively evaluated either during their hospital stay or in the outpatient setting using DT as well as the 40 item problem list. Clinical and demographic data were recorded. We performed an analysis regarding frequency of indicated topics and evaluated their relevance for patients’ psychosocial well-beings via Pearson correlations with the DT score. RESULTS Data of n = 670 patients were analyzed. Mean age was 52 years (SD = 14, range 18–81), most of the patients harbored WHO°I tumors (37%) and WHO°IV tumors (28%). Male to female ratio was 1:1, 17% were assessed preoperatively, 40% postoperatively and 43% during adjuvant therapy or follow-up. 14% of the patients faced a tumor recurrence at assessment. Mean score of DT was 5.23 (SD = 2.9, range 0–10). Applying a cut-off score ≥ 4, 61% reported distress (≥ 5: 46% and ≥ 6: 37%). Regarding the relevance of the problem list for BTP, emotional problems (e. g., anxiety, depression) were most frequently reported. A total of 14/40 (35 %) of items were endorsed by less than 10% of patients. With exception of emotional problems all areas were reflected: practical problems (e. g., problems with child care or insurance), social problems (e. g., problems with children), spiritual concerns (e. g., loss of faith), and physical problems (e. g., breathing, fever). However, some of these rarely reported problems were of relevance for patients’ psychosocial well-being as indicated by significant correlations between the respective item and the DT score. This was, for example, the case for problems with childcare (r = .106; p < .01) or breathing (r = .125; p = .001). CONCLUSION Tools developed for cancer patients do not yet perfectly reflect all needs of BTP. Based on our data, we suggest further adjustments of available tools. Yet, it should be taken into account that subgroups of BTP may require different problem lists in the DT, as we observed some topics (e.g. breathing) probably be related to BTP under chemotherapy or steroids only. Moreover, our data require cross-cultural validation as especially results regarding practical problems and insurance might differ in cultures with different social security systems.


2009 ◽  
Vol 17 (2) ◽  
pp. 61-68 ◽  
Author(s):  
Alistair Campbell ◽  
Suzanne K. Steginga ◽  
Megan Ferguson ◽  
Alison Beeden ◽  
Melissa Walls ◽  
...  

2011 ◽  
Vol 21 (7) ◽  
pp. 730-736 ◽  
Author(s):  
S. Gunnarsdottir ◽  
G. H. Thorvaldsdottir ◽  
N. Fridriksdottir ◽  
B. Bjarnason ◽  
F. Sigurdsson ◽  
...  

2008 ◽  
Vol 17 (10) ◽  
pp. 959-966 ◽  
Author(s):  
Diana Zwahlen ◽  
Niels Hagenbuch ◽  
Margaret I. Carley ◽  
Christopher J. Recklitis ◽  
Stefan Buchi

Author(s):  
Lekka Dimitra ◽  
Aggeliki Rapti ◽  
Dimitra Karkania ◽  
Argyri Evmolpidi ◽  
George Moussas ◽  
...  

2015 ◽  
Vol 33 (7_suppl) ◽  
pp. 113-113
Author(s):  
Maria Angerer-Shpilenya ◽  
Axel Heidenreich

113 Background: Tumor disease has not only somatic but also psychological impact on patients with complete change of life dimension. This resonates not only to the patients, their relatives and friends, but also to the therapy. A precise screening helps to determine the stress factor, to capture the psychological comorbidity and to initiate an early psycho-social care. Methods: 420 patients with various tumors got since October 2011 in the Urological Clinic of Aachen University Hospital screening using a Distress Thermometer. 410 patients were stationary and 10 patients came to the outpatient (ambulant) chemotherapy. 23 of the 40 questions of the Distress Thermometer depend on somatic complaints of patients. The other 17 questions cover the psycho-social problems. Results: 141 of the 420 patients reported to have a low stress level by the tumor. 139 patients showed, according to the Distress Thermometer, an average and 140 patients significantly higher stress level. This means that 279 of the 420 patients need a psycho-oncological counseling and possibly even further care and treatment. The most common entered symptoms were fears, nervousness, sleep disturbances, fatigue, sadness and worry. Depending on the wishes of the patient the psycho-oncological consultation was initiated. Only completing the Distress Thermometer helps the patient to face their problems and worries and makes perhaps the first great step in the perception of the disease. Since January 2012 a new component was inserted into the discharge reports of the tumor patients. This component contains the recommendation, depending on the result of the Distress Thermometer, to start if necessary the professional psycho-oncological support. That gives the patients a sense of security and a feeling not to fight alone against the disease. Conclusions: A targeted screening and an interdisciplinary, together with psycho-oncologists, care to cancer patients support them and their families at all stages of the disease, helps to deal with the new life situation and can possibly also increase the patient's compliance and the therapeutic response.


2020 ◽  
Vol 38 (29_suppl) ◽  
pp. 197-197
Author(s):  
Jade Zhou ◽  
Shelly Kane ◽  
Carl Curtis ◽  
Celia Ramsey ◽  
Melody Ann Akhondzadeh ◽  
...  

197 Background: Accurate TNM staging of malignancy is essential to quality care of cancer patients but maintaining consistent documentation of appropriate staging remains a challenge. We identified documentation of TNM staging at our institution to be below target levels. We sought to improve documentation of staging in all patients at our cancer center with a diagnosis of malignancy by implementing both automated and manual reminders through our electronic medical record (EMR) software (Epic), as well as by using team accountability. Methods: We defined an expectation that all patients seen at UC San Diego Moores Cancer Center with a billing diagnosis of malignancy would have TNM staging documented in the EMR within 1 month of their initial visit. The project started in 1/2016, with a phased rollout to individual teams, including education and outreach prior to the start of performance tracking. We used the AJCC staging module in Epic and focused on all new patient visits with a billing diagnosis of malignancy. Providers were asked to add this diagnosis to the problem list and then document the stage using the AJCC staging module in EPIC. We tracked compliance by individual provider and by team and emailed performance reports to all providers on a monthly basis. To facilitate compliance, we initiated automatic Epic messages to providers for an unstaged cancer diagnosis on the problem list and followed up with a personal email from administrative staff if documentation was not completed in a timely manner. Results: At the initiation of this project, there was no standardized documentation of cancer staging. The project was phased in with the skin cancer and head and neck cancers teams in phase I. Compliance in the initial month of measurement was 28%. Within 3 months of implementation of the project, compliance was over 50%, and within 27 months, over 90%. Compliance has remained > 90% since. For 3/2020, 368 patients were eligible for staging and 98% were staged within a month of their visit. Conclusions: Documentation of TNM staging of malignancy was significantly improved by both automated and personal reminders with a vital component of team accountability. Further efforts to improve the current practice and culture of documentation for diagnosed cancer patients remains a crucial aspect of quality and safety.


Sign in / Sign up

Export Citation Format

Share Document